Disclosed positions

Estimated from their latest filings — positions may have changed since

$3.21M

combined est. value

Stock	Shares	Price	Value	Weight	As of
CGEMCullinan Therapeutics, Inc.	159,968	$15.36	$2.46M	77%	2026-02-24
WSRWhitestone REIT	39,478	$18.98	$749.1K	23%	2025-12-24

CGEM

Cullinan Therapeutics, Inc.

$2.46M

159,968 sh

WSR

Whitestone REIT

$749.1K

39,478 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 3

Stock	Transaction	Date	~6mo later
CGEMCullinan Therapeutics, Inc.	Sell $66.3K · 4,582 sh	2026-02-24	—
CGEMCullinan Therapeutics, Inc.	Sell $67.9K · 4,982 sh	2026-02-20	—
WSRWhitestone REIT	Grant $87.2K · 6,368 sh	2025-12-24	—
CGEMCullinan Therapeutics, Inc.	Sell $44.8K · 4,632 sh	2025-12-18	—

CGEMSell

2026-02-24 · Cullinan Therapeutics, Inc.

$66.3K

—

CGEMSell

2026-02-20 · Cullinan Therapeutics, Inc.

$67.9K

—

WSRGrant

2025-12-24 · Whitestone REIT

$87.2K

—

CGEMSell

2025-12-18 · Cullinan Therapeutics, Inc.

$44.8K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.